We are live on ! Find out more
VTRS icon

Viatris

542 hedge funds and large institutions have $12.5B invested in Viatris in 2016 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 153 increasing their positions, 235 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

61.25% more ownership

Funds ownership: 0%61.25% (+61%)

36% more funds holding in top 10

Funds holding in top 10: 1419 (+5)

1% less first-time investments, than exits

New positions opened: 97 | Existing positions closed: 98

2% less capital invested

Capital invested by funds: $12.7B → $12.5B (-$220M)

3% less funds holding

Funds holding: 556542 (-14)

35% less repeat investments, than reductions

Existing positions increased: 153 | Existing positions reduced: 235

41% less call options, than puts

Call options by funds: $267M | Put options by funds: $449M

Holders
542
Holders Change
-14
Holders Change %
-2.52%
% of All Funds
13.55%
Holding in Top 10
19
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+35.71%
% of All Funds
0.47%
New
97
Increased
153
Reduced
235
Closed
98
Calls
$267M
Puts
$449M
Net Calls
-$182M
Net Calls Change
-$146M

VTRS Hedge Fund Activity: Q4 2016 in Review

542 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q4 2016, worth a combined $12.5B — down 1.7% from $12.7B a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of VTRS and 97 opened new positions — a net loss of 1 holder — while 235 trimmed existing stakes and 153 added.

The largest buyer was Appaloosa LP, opening a new position worth an estimated $122M. The largest seller was T. Rowe Price Associates, cutting an estimated $130M.

  • 542 institutional investors held Viatris (VTRS) as of Q4 2016, down from 556 in Q3 2016.
  • Funds reported $12.5B of Viatris stock for Q4 2016, down 1.7% quarter-over-quarter.
  • 97 funds opened new Viatris positions in Q4 2016 and 98 closed out, a net change of -1 holder.
  • The largest Viatris buyer in Q4 2016 was Appaloosa LP, an estimated $122M added.
  • The largest Viatris seller in Q4 2016 was T. Rowe Price Associates, an estimated $130M sold.

Based on aggregated 13F filings for Q4 2016.